1999 Richard J. Duma/NFID Annual Press Conference and Symposium on Infectious Diseases
Contact: Terry LaMotte
(301) 656-0003
Fax: (301) 907-0878
E-Mail: tmlamotte@aol.com
212/371-2200
Eroding Public Trust in Immunizations and Forgotten Historical Diseases Are Growing Global Health Threats, Experts Warn
What
The 4th NFID/Richard J. Duma Annual Press Conference and Symposium on Infectious Diseases, sponsored by the National Foundation for Infectious Diseases (NFID). Topics will focus primarily on infectious disease education and late-breaking infectious disease news such as hepatitis C, restoring the public trust in vaccination, tuberculosis in the new millennium, the forgotten epidemic of herpes, and the role of chlamydia in atherosclerosis.
When
Thursday, April 22, 1999, from 10 a.m. to 12 p.m., followed by a complimentary luncheon.
Where
The First Amendment Room of the National Press Club, 529 14th Street, NW, 13th Floor, Washington, D.C.
Why
- To discuss a wide variety of new and late-breaking infectious disease topics.
- To hear predictions for breaking infectious disease news in 2000.
- To learn about important infectious disease problems and possible solutions.
- To have informal discussions with internationally renowned infectious disease experts.
Who & Topics
- Ralph Nader, consumer advocate, on the Princeton Project 55's mission to combat tuberculosis;
- Kenneth Castro, M.D., Centers for Disease Control and Prevention, Tuberculosis in the New Millennium: Why We Need to Keep Up Our Guard;
- Gray Davis, Ph.D., Sexual Health Communications, Whatever Happened to Herpes? The Forgotten Epidemic;
- Bruce G. Gellin, M.D., M.P.H., Infectious Diseases Society of America, Restoring the Public Trust in Vaccinations: A New IDSA Initiative;
- J. Thomas Grayston, M.D., University of Washington, The Role of Chlamydia in Atherosclerosis;
- Leslye D. Johnson, Ph.D., National Institutes of Health, Why You Should Know About Hepatitis C.
NFID is a national, nonprofit 501(c)(3) public foundation established in 1973 to support infectious disease research, to sponsor public and professional education programs, and to aid in the prevention of infectious diseases.